Oxidized LDL (oxLDL) activates the angiotensin II type 1 receptor by binding to the lectin-like oxLDL receptor

LOX-1 Deletion Limits Cardiac Angiogenesis in Mice Given Angiotensin II

(2014) Xianwei Wang et al.   CARDIOVASCULAR DRUGS AND THERAPY

An Alternative Protein Standard to Measure Activity of LOX-1 Ligand Containing apoB (LAB) - Utilization of Anti-LOX-1 Single- Chain Antibody Fused to apoB Fragment

(2011) Shin Iwamoto et al.   Journal of Atherosclerosis and Thrombosis

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

(2011) Christian Besler et al.   JOURNAL OF CLINICAL INVESTIGATION

Receptor heteromerization and drug discovery

(2010) Raphael Rozenfeld et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease

(2008) Sarah Dunn et al.   BIOCHEMICAL JOURNAL

Oxidized LDL Receptor LOX-1 Binds to C-Reactive Protein and Mediates Its Vascular Effects

(2008) Y. Fujita et al.   CLINICAL CHEMISTRY

A role for VEGF as a negative regulator of pericyte function and vessel maturation

(2008) Joshua I. Greenberg et al.   NATURE

Differential Bonding Interactions of Inverse Agonists of Angiotensin II Type 1 Receptor in Stabilizing the Inactive State

(2007) Shin-ichiro Miura et al.   MOLECULAR ENDOCRINOLOGY